NCT07405099 2026-02-27
Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease
National Taiwan University Hospital
Enrolling by invitation
Clinical Trials
12 trialsNCT07396662 2026-02-09
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
National Taiwan University Hospital
Recruiting
NCT06478056 2026-02-06
VEINOPAN
University Hospital, Rouen
Phase NA Completed
NCT07382791 2026-02-03
Delayed Gastric Emptying After Pancreatic Surgery
National Taiwan University Hospital
Recruiting
NCT04594772 2025-07-02
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
University of Cincinnati
Phase 2 Active not recruiting
NCT06980792 2025-05-20
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Azienda Ospedaliero-Universitaria di Modena
Completed
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT06093009 2023-10-24
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
National Cheng-Kung University Hospital
Completed
NCT03801915 2023-03-21
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03891472 2019-11-13
Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer
Medical University of Silesia
Phase 2 Completed
NCT02823678 2017-07-28
Pancreas Volume and Diabetes Status Following Pancreatectomy
Florida Hospital Tampa Bay Division
Unknown
NCT02117895 2016-08-11
Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail
Fudan University
Phase 3 Unknown